Investors Buy CVS Health (CVS) on Weakness

Investors bought shares of CVS Health Corp (NYSE:CVS) on weakness during trading on Tuesday. $121.21 million flowed into the stock on the tick-up and $60.56 million flowed out of the stock on the tick-down, for a money net flow of $60.65 million into the stock. Of all companies tracked, CVS Health had the 6th highest net in-flow for the day. CVS Health traded down ($0.01) for the day and closed at $80.44

Several equities research analysts have commented on CVS shares. Jefferies Group set a $76.00 target price on shares of CVS Health and gave the stock a “hold” rating in a research report on Monday, December 4th. Vetr lowered shares of CVS Health from a “buy” rating to a “hold” rating and set a $77.11 target price on the stock. in a research report on Thursday, January 4th. Robert W. Baird reiterated a “hold” rating and issued a $77.00 price objective on shares of CVS Health in a research report on Friday, October 27th. Royal Bank of Canada set a $95.00 price objective on shares of CVS Health and gave the stock a “buy” rating in a research report on Monday, December 4th. Finally, UBS Group upgraded shares of CVS Health from an “outperform” rating to a “strong-buy” rating in a research report on Thursday, January 4th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $87.25.

The company has a market cap of $81,490.00, a P/E ratio of 16.62, a price-to-earnings-growth ratio of 1.26 and a beta of 0.90. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67.

CVS Health (NYSE:CVS) last announced its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.01. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The firm had revenue of $46.18 billion during the quarter, compared to the consensus estimate of $46.17 billion. During the same quarter in the previous year, the company posted $1.64 EPS. The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. equities research analysts anticipate that CVS Health Corp will post 5.89 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, February 2nd. Investors of record on Wednesday, January 24th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.49%. The ex-dividend date is Tuesday, January 23rd. CVS Health’s payout ratio is 41.32%.

In related news, EVP Lisa Bisaccia sold 29,445 shares of the business’s stock in a transaction dated Thursday, December 21st. The shares were sold at an average price of $75.00, for a total value of $2,208,375.00. Following the completion of the transaction, the executive vice president now owns 15,556 shares of the company’s stock, valued at approximately $1,166,700. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.61% of the company’s stock.

A number of hedge funds have recently made changes to their positions in the stock. Fieldpoint Private Securities LLC increased its stake in shares of CVS Health by 333.3% during the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $105,000 after acquiring an additional 1,000 shares during the last quarter. Wealthcare Advisory Partners LLC increased its stake in shares of CVS Health by 330.3% during the 3rd quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock valued at $105,000 after acquiring an additional 991 shares during the last quarter. Arcadia Investment Management Corp MI increased its stake in shares of CVS Health by 119.6% during the 3rd quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock valued at $108,000 after acquiring an additional 726 shares during the last quarter. MPS Loria Financial Planners LLC acquired a new position in shares of CVS Health during the 2nd quarter valued at about $119,000. Finally, Gemmer Asset Management LLC increased its stake in shares of CVS Health by 15.3% during the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock valued at $121,000 after acquiring an additional 200 shares during the last quarter. 81.70% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/01/23/investors-buy-cvs-health-cvs-on-weakness-2.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply